A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)

计划入组 1,758 人 · 首次发布于 2017 年 7 月 28 日

JOTROL PK, Safety, and Food Effect Assessment

计划入组 24 人 · 首次发布于 2020 年 12 月 16 日

Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally

计划入组 46 人 · 首次发布于 2016 年 11 月 8 日

Intranasal COVID-19 vaccine(Food and Drug Administration)

Autologous mesenchymal stem cells(Belarus Ministry of Public Health)

E-selectin-targed drug carrier(Uni of Groningen, Leiden and Utrecht)

US NANO FOOD AND DRUG (HK) LIMITED

Hong Kong, China

MINISTRY OF SCIENCE AND TECHNOLOGY

Israel

JAPAN ORGANIZATION OF OCCUPATIONAL HEALTH AND SAFETY

Japan

South Korea's MFDS to Increase New Drug Approval Fees to Expedite Review Process

Korea Approves Voxzogo for Pediatric Chondrodysplasia Treatment

Dapagliflozin Safety Profile: Comparative Analysis of EMA, FDA, and Korean Post-Market Surveillance